Elevated PSA was also significantly associated with prostate cancer diagnosis (p < 0.001, Fisher’s exact test) and benign biopsy findings (p < 0.001, Fisher’s exact test); all the subgroups under nonbiopsied were combined into one Fisher's exact test to avoid overtesting (Table 1) (Figure 1). The gene discussed is KLK3; the disease is prostate carcinoma.